Kronos Bio
KRON
KRON was delisted on the 20th of June, 2025.
56 hedge funds and large institutions have $18.7M invested in Kronos Bio in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 7 closing their positions.
57% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 7
20% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 10
6% more funds holding
Funds holding: 53 → 56 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.11% less ownership
Funds ownership: 32.68% → 32.56% (-0.11%)
5% less capital invested
Capital invested by funds: $19.7M → $18.7M (-$1.03M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$947K |
| 2 |
DAM
Deltec Asset Management
New York
|
+$189K |
| 3 |
Renaissance Technologies
New York
|
+$182K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$93.9K |
| 5 |
Squarepoint
New York
|
+$92.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCIG
Partners Capital Investment Group
Boston,
Massachusetts
|
-$1.02M |
| 2 |
AI
Acuitas Investments
Seattle,
Washington
|
-$554K |
| 3 |
Millennium Management
New York
|
-$311K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
-$200K |
| 5 |
Two Sigma Advisers
New York
|
-$175K |
KRON Hedge Fund Activity: Q4 2024 in Review
56 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2024, worth a combined $18.7M — down 5.3% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new KRON positions and 7 closed out — a net gain of 4 holders — while 12 added to existing stakes and 10 trimmed.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $947K. The largest seller was Partners Capital Investment Group, cutting an estimated $1.02M.
- 56 institutional investors held Kronos Bio (KRON) as of Q4 2024, up from 53 in Q3 2024.
- Funds reported $18.7M of Kronos Bio stock for Q4 2024, down 5.3% quarter-over-quarter.
- 11 funds opened new Kronos Bio positions in Q4 2024 and 7 closed out, a net change of +4 holders.
- The largest Kronos Bio buyer in Q4 2024 was Tang Capital Management, an estimated $947K added.
- The largest Kronos Bio seller in Q4 2024 was Partners Capital Investment Group, an estimated $1.02M sold.
Based on aggregated 13F filings for Q4 2024.